Sudden cardiac death unresponsive to implantable defibrillator therapy: An urgent target for clinicians, industry and government

Journal of Interventional Cardiac Electrophysiology

Volumn 14, Issue 2, 2005, Pages 71-78

  Anderson, Kelley P ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

Cardiac electrophysiology; Heart failure; Implantable defibrillator; Sudden death; Ventricular fibrillation

Indexed keywords

CLINICAL PRACTICE; CLINICAL TRIAL; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; GOVERNMENT; HEALTH CARE INDUSTRY; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MEDICAL INFORMATION; MEDICAL RESEARCH; MEDICAL TECHNOLOGY; PATIENT; PHYSICIAN; POST HOC ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK; RISK REDUCTION; STATISTICAL SIGNIFICANCE; STORAGE; SUDDEN DEATH; SURVIVAL; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; EQUIPMENT FAILURE ANALYSIS; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 29344461788     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-005-4547-9     Document Type: Review

References (35)

1. Mirowski M, Reid PR, Winkle RA, Mower MM, Watkins L Jr, Stinson EB, Griffith LS, Kallman CH, Weisfeldt ML. Mortality in patients with implanted automatic defibrillators. Ann Intern Med 1983;98:585-588.
2. Echt DS, Armstrong K, Schmidt P, Oyer PE, Stinson EB, Winkle RA. Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation 1985;71:289-296.
3. Fogoros RN, Fiedler SB, Elson JJ. The automatic implantable cardioverter-defibrillator in drug-refractory ventricular tachyarrhythmias. Ann Intern Med 1987;107(5):635-641.
4. Kelly PA, Cannom DS, Garan H, Mirabal GS, Harthorne JW, Hurvitz RJ, Vlahakes GJ, Jacobs ML, Ilvento JP, Buckley MJ, Ruskin JN. The automatic implantable cardioverter-defibrillator: Efficacy, complications and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol 1988;11:1278-1286.
5. Winkle RA, Mead RH, Ruder MA, et al. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989;13:1353-1361.
6. Fogoros RN, Elson JJ, Bonnet CA. Actuarial incidence and pattern of occurrence of shocks following implantation of the automatic implantable cardioverter defibrillator. Pacing Clin Electrophysiol 1989;12:1465-1473.
7. Levine JH, Mellits ED, Baumgardner RA, Baumgardner RA, Veltri EP, Mower M, Grunwald L, Guarnieri T, Aarons D, Griffith LS. Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators. Circulation 1991;84:558-566.
8. Newman D, Sauve MJ, Herre J, Langberg JJ, Lee MA, Titus C, Franklin J, Scheinman MM, Griffin JC. Survival after implantation of the cardioverter defibrillator. Am J Cardiol 1992;69:899-903.
9. Powell AC, Fuchs T, Finkelstein DM, Garan H, Cannom DS, McGovern BA, Kelly E, Vlahakes GJ, Torchiana DF, Ruskin JN. Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation 1993;88:1083-1092.
10. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337(22):1576-1583.
11. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH. Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004 May 20;350:2151-2158.
12. Kuck KH, Cappato R, Siebels J, Rueppel R. CASH Investigators. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest - The Cardiac Arrest Study Hamburg (CASH). Circulation 2000,1915;102:748-754.
13. Connolly S, Gent M, Roberts R, Dorian P, Roy D, Sheldon R, Mitchell L, Green M, Klein G, O'Brien B, CIDS I. Canadian implantable defibrillator study (CIDS) - A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-1302.
14. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996;335:1933-1940.
15. Bigger JT Jr, DiMarco JP, Rottman JN. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery - reply. N Engl J Med 1998;338:1228-1228.
16. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883.
17. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ. DINA-MIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-2488.
18. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352(3):225-237.
19. Ezekowitz JA, Armstrong PW, McAlister FA. Implantable cardioverter defibrillators in primary and secondary prevention: A systematic review of randomized, controlled trials. Ann Intern Med 2003;138(6):445-452.
20. Lee DS, Green LD, Liu PP, Dorian P, Newman DM, Grant FC, Tu JV, Alter DA. Effectiveness of implantable defibrillators for preventing arrhythmic events and death - A meta-analysis. J Am Coll Cardiol 2003;41:1573-1582.
21. Al-Khatib SM, Sanders GD, Mark DB, Lee KL, Bardy GH, Bigger JT, Buxton AE, Connolly S, Kadish A, Moss A, Feldman AM, Ellenbogen KA, Singh S, Califf RM. Expert panel participating in a Duke Clinical Research Institute-sponsored conference. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. Am Heart J 2005:1020-1034.
22. Packer DL, Bernstein R, Wood F, Boehmer J, Carlson M, Frantz RP, Mitchell LB, McNulty SE, Poole J, Rogers J, Anderson J, Walsh MN, Lee KL, Bardy GH, Boineau R, Domanski M. Impact of amiodarone versus implantable cardioverter defibrillator therapy on the mode of death in congestive heart failure patients in the SCDHeFT trial (abstr). Heart Rhythm 2005;2:S39.
23. Gornick CC, Hauser RG, Almquist AK, Maron BJ. Unpredictable implantable cardioverter-defibrillator pulse generator failure due to electrical overstress causing sudden death in a young high-risk patient with hypertrophic cardiomyopathy. Heart Rhythm 2005;2:681-683.
24. Steinbrook R. The controversy over Guidant's implantable defibrillators. N Engl J Med 2005;353(3):221-224.
25. Mitchell LB, Pineda EA, Titus JL, Bartosch PM, Benditt DG. Sudden death in patients with implantable cardioverter defibrillators: The importance of post-shock electromechanical dissociation. J Am Coll Cardiol 2002;39:1323-1328.
26. AVID Investigators. Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Am Coll Cardiol 1999;34:1552-1559.
27. Bigger JT Jr, Whang W, Rottman JN, Kleiger RE, Gottlieb CD, Namerow PB, Steinman RC, Estes NA 3rd. Mechanisms of death in the CABG Patch trial: A randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation 1999;99:1416-1621.
28. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML. MADIT-II Investigators. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004;43:1459-1465.
29. Heart Rhythm Society, Patients and the Public, Treatments, Implanted Cardiac Defibrillators: http://www.hrspatients.org/patients/treatments/ cardiac_defibrillators/default.asp (last accessed August 14, 2005).
30. Heart Rhythm Society, Patients and the Public, Treatments, Implanted Cardiac Defibrillators, Common Questions about ICDs: http://www.hrspatients.org/ patients/treatments/cardiac_defibrillators/common_questions.asp (last accessed August 14, 2005).
31. Gorsett A. Urgent Medical Device Safety Information & Corrective Action. Guidant "Dear Doctor" Letter, June 17, 2005.
32. Salukhe TV, Dimopoulos K, Sutton R, Coats AJ, Piepoli M, Francis DP. Life-years gained from defibrillator implantation: Markedly nonlinear increase during 3 years of follow-up and its implications. Circulation 2004;109(15):1848-1853.
33. Owens DK, Sanders GD, Heidenreich PA, McDonald KM, Hlatky MA. Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator. Am Heart J 2002;144:440-448.
34. Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Operations Manual 1998;8:1-3.1
35. Saksena S. Prophylactic ICDs: Can (and will) the medical marketplace decide their role? J Interv Card Electrophysiol 2005;12(3):175-176.